Variant report
Variant | esv1832625 |
---|---|
Chromosome Location | chr10:1582689-1585629 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:1575954..1577793-chr10:1581018..1583790,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570149123 | chr10:1582694-1582695 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545375024 | chr10:1582698-1582699 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs12243697 | chr10:1582724-1582725 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376943255 | chr10:1582741-1582742 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112354005 | chr10:1582743-1582744 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs566378971 | chr10:1582744-1582745 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs12243701 | chr10:1582749-1582750 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs201486599 | chr10:1582761-1582762 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12243709 | chr10:1582766-1582767 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs12243710 | chr10:1582768-1582769 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs75357462 | chr10:1582774-1582775 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558786502 | chr10:1582784-1582785 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371342594 | chr10:1582813-1582814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs77025241 | chr10:1582817-1582818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs55758876 | chr10:1582821-1582822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs113706838 | chr10:1582826-1582827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140391390 | chr10:1582832-1582833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs80144459 | chr10:1582838-1582839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs61831931 | chr10:1582856-1582857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs61831932 | chr10:1582857-1582858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs557749587 | chr10:1582861-1582862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138205754 | chr10:1582870-1582871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs74537370 | chr10:1582874-1582875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs80190010 | chr10:1582876-1582877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs200602858 | chr10:1582881-1582882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77555026 | chr10:1582901-1582902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs74543053 | chr10:1582905-1582906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575654514 | chr10:1582911-1582912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs369951179 | chr10:1582912-1582913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs543392374 | chr10:1582914-1582915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74339790 | chr10:1582921-1582922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs185181171 | chr10:1582923-1582924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188667179 | chr10:1582930-1582931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs74762624 | chr10:1582932-1582933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs80040548 | chr10:1582934-1582935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs141555417 | chr10:1582958-1582959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191604810 | chr10:1582959-1582960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs369906930 | chr10:1582966-1582967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs183756137 | chr10:1582976-1582977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs188134311 | chr10:1582978-1582979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs375368121 | chr10:1583020-1583021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs180675157 | chr10:1583022-1583023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187211668 | chr10:1583037-1583038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544326756 | chr10:1583038-1583039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs373549478 | chr10:1583039-1583040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs369017743 | chr10:1583059-1583060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565166378 | chr10:1583060-1583061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372594904 | chr10:1583061-1583062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs377246776 | chr10:1583067-1583068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370391360 | chr10:1583086-1583087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 20409316 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Cancer | 21129771 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Wilms tumour | 19047088 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Barakat syndrome | 22470819 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Autism | 18414403 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Breast cancer | 22032731 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 17363583 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21785460 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Autism | 22543975 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:1581000-1585400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr10:1581200-1588400 | Weak transcription | Dnd41 | blood |
3 | chr10:1582400-1585400 | Weak transcription | Brain Germinal Matrix | brain |
4 | chr10:1582600-1582800 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr10:1582800-1584000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr10:1583200-1587800 | Weak transcription | Spleen | Spleen |
7 | chr10:1584000-1584400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr10:1584400-1586400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr10:1585200-1585400 | Flanking Bivalent TSS/Enh | Breast Myoepithelial Primary Cells | Breast |
10 | chr10:1585200-1585400 | Flanking Bivalent TSS/Enh | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr10:1585200-1585400 | Enhancers | Brain Anterior Caudate | brain |
12 | chr10:1585200-1585400 | Enhancers | Fetal Muscle Leg | muscle |
13 | chr10:1585200-1594800 | Weak transcription | Right Atrium | heart |
14 | chr10:1585400-1585600 | Active TSS | iPS DF 6.9 Cell Line | embryonic stem cell |
15 | chr10:1585400-1585600 | Bivalent Enhancer | Breast Myoepithelial Primary Cells | Breast |
16 | chr10:1585400-1585600 | Bivalent/Poised TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
17 | chr10:1585400-1586000 | Enhancers | Fetal Brain Female | brain |
18 | chr10:1585400-1586200 | Weak transcription | Brain Anterior Caudate | brain |
19 | chr10:1585400-1587400 | Enhancers | Brain Germinal Matrix | brain |